{"id":"https://openalex.org/W1563370352","doi":"https://doi.org/10.1046/j.1365-2125.2000.00216.x","title":"Intracranial haemorrhage and use of selective serotonin reuptake inhibitors","display_name":"Intracranial haemorrhage and use of selective serotonin reuptake inhibitors","alternate_titles":[],"publication_year":2000,"publication_date":"2000-07-01","ids":{"openalex":"https://openalex.org/W1563370352","doi":"https://doi.org/10.1046/j.1365-2125.2000.00216.x","mag":"1563370352","pmid":"https://pubmed.ncbi.nlm.nih.gov/10886117","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2014962"},"language":"en","primary_location":{"id":"doi:10.1046/j.1365-2125.2000.00216.x","doi":"https://doi.org/10.1046/j.1365-2125.2000.00216.x","is_oa":true,"landing_page_url":"https://doi.org/10.1046/j.1365-2125.2000.00216.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2125.2000.00216.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1563370352"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2125.2000.00216.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086869616","display_name":"Francisco Jos\u00e9 de Abajo","orcid":"https://orcid.org/0000-0001-9119-8646","observed_orcids":["https://orcid.org/0000-0001-9119-8646"]},"institutions":[{"id":"https://openalex.org/I4210142787","display_name":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios","ror":"https://ror.org/043fs9135","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210098440","https://openalex.org/I4210142787"]}],"countries":["ES"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Francisco J. De Abajo","raw_affiliation_strings":["Divisi\u00f3n de Farmacoepidemiolog\u00eda y Farmacovigilancia Agencia Espa\u00f1ola del Medicamento, Madrid, Spain","Divisi\u00f3n de Farmacoepidemiolog\u00eda y Farmacovigilancia Agencia Espa\u00f1ola del Medicamento, Madrid, Spain and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Divisi\u00f3n de Farmacoepidemiolog\u00eda y Farmacovigilancia Agencia Espa\u00f1ola del Medicamento, Madrid, Spain","institution_ids":["https://openalex.org/I4210142787"]},{"raw_affiliation_string":"Divisi\u00f3n de Farmacoepidemiolog\u00eda y Farmacovigilancia Agencia Espa\u00f1ola del Medicamento, Madrid, Spain and","institution_ids":["https://openalex.org/I4210142787"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065681509","display_name":"Hershel Jick","orcid":"https://orcid.org/0000-0003-4270-5992","observed_orcids":["https://orcid.org/0000-0003-4270-5992"]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]},{"id":"https://openalex.org/I4210115736","display_name":"Boston Collaborative Drug Surveillance Program","ror":"https://ror.org/0228drn10","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210115736"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hershel Jick","raw_affiliation_strings":["the Boston Collaborative Drug Surveillance Program, Boston University Medical Center, Lexington, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Boston Collaborative Drug Surveillance Program, Boston University Medical Center, Lexington, Massachusetts, USA","institution_ids":["https://openalex.org/I111088046","https://openalex.org/I4210115736"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111453437","display_name":"Laura E. Derby","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]},{"id":"https://openalex.org/I4210115736","display_name":"Boston Collaborative Drug Surveillance Program","ror":"https://ror.org/0228drn10","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210115736"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Laura Derby","raw_affiliation_strings":["the Boston Collaborative Drug Surveillance Program, Boston University Medical Center, Lexington, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Boston Collaborative Drug Surveillance Program, Boston University Medical Center, Lexington, Massachusetts, USA","institution_ids":["https://openalex.org/I111088046","https://openalex.org/I4210115736"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025121087","display_name":"Susan Sara Jick","orcid":"https://orcid.org/0000-0002-2215-1067","observed_orcids":["https://orcid.org/0000-0002-2215-1067"]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]},{"id":"https://openalex.org/I4210115736","display_name":"Boston Collaborative Drug Surveillance Program","ror":"https://ror.org/0228drn10","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210115736"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Susan Jick","raw_affiliation_strings":["the Boston Collaborative Drug Surveillance Program, Boston University Medical Center, Lexington, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Boston Collaborative Drug Surveillance Program, Boston University Medical Center, Lexington, Massachusetts, USA","institution_ids":["https://openalex.org/I111088046","https://openalex.org/I4210115736"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078151572","display_name":"Stephen Schmitz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]},{"id":"https://openalex.org/I4210115736","display_name":"Boston Collaborative Drug Surveillance Program","ror":"https://ror.org/0228drn10","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210115736"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stephen Schmitz","raw_affiliation_strings":["the Boston Collaborative Drug Surveillance Program, Boston University Medical Center, Lexington, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Boston Collaborative Drug Surveillance Program, Boston University Medical Center, Lexington, Massachusetts, USA","institution_ids":["https://openalex.org/I111088046","https://openalex.org/I4210115736"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5086869616"],"corresponding_institution_ids":["https://openalex.org/I4210142787"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":1.6956,"has_fulltext":true,"cited_by_count":102,"citation_normalized_percentile":{"value":0.82843501,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"50","issue":"1","first_page":"43","last_page":"47"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11763","display_name":"Intracerebral and Subarachnoid Hemorrhage Research","score":0.3131999969482422,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11763","display_name":"Intracerebral and Subarachnoid Hemorrhage Research","score":0.3131999969482422,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.2273000031709671,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.15060000121593475,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/intracranial-hemorrhage","display_name":"intracranial hemorrhage","score":0.9819999933242798},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.9769999980926514},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.9269999861717224},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.8939999938011169},{"id":"https://openalex.org/keywords/bleeding-disorders","display_name":"bleeding disorders","score":0.652999997138977},{"id":"https://openalex.org/keywords/subarachnoid-hemorrhage","display_name":"subarachnoid hemorrhage","score":0.9430000185966492},{"id":"https://openalex.org/keywords/intracerebral-hemorrhage","display_name":"intracerebral hemorrhage","score":0.9380000233650208},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.4690000116825104}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7586855888366699},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.7193374037742615},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.6328803896903992},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.5081677436828613},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.4941082298755646},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.4910905361175537},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.48973917961120605},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.46818745136260986},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4550893306732178},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.32607609033584595},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000929","descriptor_name":"Antidepressive Agents, Tricyclic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016017","descriptor_name":"Odds Ratio","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016022","descriptor_name":"Case-Control Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D020300","descriptor_name":"Intracranial Hemorrhages","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1046/j.1365-2125.2000.00216.x","doi":"https://doi.org/10.1046/j.1365-2125.2000.00216.x","is_oa":true,"landing_page_url":"https://doi.org/10.1046/j.1365-2125.2000.00216.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2125.2000.00216.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2014962","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2014962/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"},{"id":"pmid:10886117","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10886117","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of clinical pharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1046/j.1365-2125.2000.00216.x","doi":"https://doi.org/10.1046/j.1365-2125.2000.00216.x","is_oa":true,"landing_page_url":"https://doi.org/10.1046/j.1365-2125.2000.00216.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2125.2000.00216.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307771","display_name":"Bayer","ror":"https://ror.org/04hmn8g73"},{"id":"https://openalex.org/F4320311904","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1563370352.pdf","grobid_xml":"https://content.openalex.org/works/W1563370352.grobid-xml"},"referenced_works_count":19,"referenced_works":["https://openalex.org/W1691887444","https://openalex.org/W2006127303","https://openalex.org/W2006509651","https://openalex.org/W2014644245","https://openalex.org/W2073714032","https://openalex.org/W2092902579","https://openalex.org/W2124549431","https://openalex.org/W2132817862","https://openalex.org/W2157134446","https://openalex.org/W2207901890","https://openalex.org/W2332320054","https://openalex.org/W2410454863","https://openalex.org/W2415650014","https://openalex.org/W2415920315","https://openalex.org/W2419580746","https://openalex.org/W2523901509","https://openalex.org/W3027488171","https://openalex.org/W3035877465","https://openalex.org/W4239393784"],"related_works":["https://openalex.org/W2911767436","https://openalex.org/W2013372440","https://openalex.org/W3124903552","https://openalex.org/W2791111957","https://openalex.org/W2560552756","https://openalex.org/W2325299324","https://openalex.org/W2931895733","https://openalex.org/W2889938692","https://openalex.org/W2039009675","https://openalex.org/W1557314957"],"abstract_inverted_index":{"AIMS:":[0],"In":[1],"the":[2,18,35,49,60,79,87,137,143,168,274],"past":[3],"few":[4],"years":[5,102],"an":[6,52,128,146,229],"increasing":[7],"number":[8],"of":[9,20,29,37,40,51,55,62,75,90,131,145,180,186,204,233,276,292,297],"bleeding":[10,277],"disorders":[11],"have":[12],"been":[13],"reported":[14],"in":[15,72,218,228],"association":[16],"with":[17,59,78,118,127,183,193,287],"use":[19,61,185],"selective":[21],"serotonin":[22],"reuptake":[23],"inhibitors":[24],"(SSRIs),":[25],"including":[26],"serious":[27],"cases":[28,203,220],"intracranial":[30,56,132,148,181,206,293],"haemorrhage,":[31],"raising":[32],"concerns":[33],"about":[34],"safety":[36],"this":[38],"class":[39],"drugs.":[41],"The":[42,92,237,246,266],"present":[43],"study":[44,70,93,169],"was":[45,216,242,264],"performed":[46],"to":[47,114,151,214,259,273],"test":[48],"hypothesis":[50],"increased":[53,129,290,309],"risk":[54,130,267,291],"haemorrhage":[57,133,182,207,294],"associated":[58,126],"SSRIs.":[63],"METHODS:":[64],"We":[65,171,200],"carried":[66],"out":[67],"a":[68,73,105,288],"case-control":[69],"nested":[71],"cohort":[74,94],"antidepressants":[76,190,301],"users":[77,296],"UK-based":[80],"General":[81],"Practice":[82],"Research":[83],"Database":[84],"(GPRD)":[85],"as":[86,191],"primary":[88],"source":[89],"information.":[91],"encompassed":[95],"subjects":[96],"aged":[97],"between":[98],"18":[99],"and":[100,162,176,188,208,223],"79":[101],"who":[103],"received":[104],"first-time":[106],"prescription":[107],"for":[108,239],"any":[109],"antidepressant":[110],"from":[111,136,167],"January,":[112],"1990":[113],"October,":[115],"1997.":[116],"Patients":[117,139],"presenting":[119],"conditions":[120],"or":[121,254,261,279,299],"treatments":[122],"that":[123],"could":[124],"be":[125,312],"were":[134,140,164,249],"excluded":[135],"cohort.":[138,170],"followed-up":[141],"until":[142],"occurrence":[144],"idiopathic":[147,205],"haemorrhage.":[149],"Up":[150],"four":[152],"controls":[153,225],"per":[154],"case,":[155],"matched":[156,210],"on":[157],"age,":[158],"sex,":[159],"calendar":[160],"time":[161],"practice":[163],"randomly":[165],"selected":[166],"estimated":[172],"adjusted":[173,230],"odds":[174],"ratios":[175],"95%":[177],"confidence":[178],"intervals":[179],"current":[184],"SSRIs":[187,215,298],"other":[189,300],"compared":[192],"nonuse":[194],"using":[195],"conditional":[196],"logistic":[197],"regression.":[198],"RESULTS:":[199],"identified":[201],"65":[202],"254":[209],"controls.":[211],"Current":[212],"exposure":[213],"ascertained":[217],"7":[219],"(10.":[221],"8%)":[222],"24":[224],"(9.7%)":[226],"resulting":[227],"OR":[231],"(95%CI)":[232],"0.":[234],"8":[235],"(0.3,2.3).":[236],"estimate":[238],"'other":[240],"antidepressants'":[241],"0.7":[243],"(0.3,1.":[244],"6).":[245],"effect":[247,257],"measures":[248],"not":[250,270,285],"modified":[251],"by":[252],"gender":[253],"age.":[255],"No":[256],"related":[258],"dose":[260],"treatment":[262],"duration":[263],"detected.":[265],"estimates":[268],"did":[269],"change":[271],"according":[272],"location":[275],"(intracerebral":[278],"subarachnoid).":[280],"CONCLUSIONS:":[281],"Our":[282],"results":[283],"are":[284],"compatible":[286],"major":[289],"among":[295],"at":[302],"large.":[303],"However,":[304],"smaller":[305],"but":[306],"still":[307],"relevant":[308],"risks":[310],"cannot":[311],"ruled":[313],"out.":[314]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1563370352","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
